FDA Investigator Thomas C Woods
Thomas C Woods has conducted inspections on 180 sites in 1 countries as of 31 Dec 2013. See below for a list of the FDA enforcement documents resulting from those inspections.
Investigator Details
Number of Inspected Sites:
180
Last Inspection Date:
31 Dec 2013
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
United States of America
FDA Investigators that have inspected at least one site in common with Thomas C Woods:
Alan Escalona,
Alec M O'neal,
Allison C Hunter,
Allison M Scheck,
Amy L Mccarthy,
Andrew I Carr,
Andrew M Kupper,
Annemarie Kleiza,
Ariel J Cutchins,
Bailey A Uetrecht,
Benjamin D Shuler,
Brandi N Mcgrady,
Brenda C Hamilton,
Brian J Davis,
Bruce E Kummer,
Bryan J Love,
Cassandra L Winters,
Cherie T Parker,
Christian L Witkovskie,
Christina L Bigham,
Christine E Kelley,
Christopher T Middendorf,
Craig P Seaborn,
Cynthia T Cain,
Darren S Morgan,
David L Craft,
David P Moorhead,
Dell S Moller,
Diane R Mcdaniel,
Donna F Campbell,
Dorathy M Eischen,
Dyanthony T Jenkins,
Elizabeth Ll Edwards,
Elizabeth P Kinsella,
Emily E Krumel,
Evan M Kupper,
Felipe Rde Almeida,
Genevieve E Ghand,
Gina M Brackett,
Gretchen N Kilby,
Hans T Meyers,
Holly J Rapier,
Holly J Wilson,
James G Marsh,
Jason D Werne,
Javonica F Penn,
Jeffrey A Sincek,
Jennifer L Gustavus,
Jennifer L Jager,
Jennifer L Watson,
Jerry J Corwin,
John D Jaworski,
John E Russell, Jr,
Jonathan A Ferguson,
Joseph X Kaufman,
Joshua S Hunt,
Julie A Silberberg,
Karen M Bryerton,
Karen M Cooper,
Kathleen D Culver,
Kelli L Wilkinson,
Kimberly A Joseph,
Krista B Jones,
Krista T Ferry,
Lauren R Collins,
Lindsey M Schwierjohann,
Logan T Williams,
Luckner Jean Marie,
Malik S Qaiser,
Maney P Sturgill,
Marianne Allen,
Maribeth G Niesen,
Mark E Parmon,
Marlon K Turner,
Mary B Sheets,
Matt D Suedkamp,
Michael D Thatcher,
Michael E Campbell,
Michael P Sheehan,
Nadeem I Chaudhry,
Neal D Singletary, PhD,
Nicholas L Paulin,
Nisha C Patel,
Payne,
Philip S Woodward,
Pifer,
Richard W Berning,
Robert E Hultman,
Robert Rodriguez,
Robert W Hudson,
Rosanna M Goodrich,
Roy C Stephens,
Rterry Bolen,
Said H Muse,
Samuel A Hamblin,
Shannon A Gregory,
Steven P Eastham,
Susan M Taylor,
Talmane J Fisher,
Tamara M Kays,
Tamara N Champion,
Tammy M Phillips,
Teresa K Kastner,
Thomas B Smith,
Thomas J Prigge,
Thomas W Nojek,
Tracey L Harris,
Troy A Huffman,
Wen Ning Chan (Sally),
William K Ducloux
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more